Kidney cancer, Renal cell cancer, Secondary cancers
Results
Phase 2/3
This trial compared taking sunitinib or pazopanib continuously with having planned breaks in treatment. It was for people with advanced renal cell cancer.
The trial was open for people to join between 2012 and 2017. The team published the results in 2023.
Recruitment start: 13 January 2012
Recruitment end: 12 September 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Janet Brown
Cancer Research UK Leeds Clinical Trials Unit at University of Leeds
University of Sheffield
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
NIHR Health Technology Assessment (HTA) programme
Last reviewed: 8 February 2024
CRUK internal database number: 8740
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
